Verified July 2026 · Cited to primary sources
Peptide comparisons: head to head, by the evidence.
The popular "X vs Y" peptide matchups, each compared on strength of human evidence (Grade A to F), legal status, safety, primary use, and cost. The grade is assigned by our rubric, not by what we can sell, so you get the honest verdict on which wins and for what.
One thing worth settling before you compare any two of them, because it changes how you read every row below: are peptides steroids? They are not, they work through a different mechanism, and the two are not interchangeable on legality, on evidence or on risk.
- BPC-157 vs TB-500BPC-157: Grade DTB-500: Grade D
- BPC-157 vs KPVBPC-157: Grade DKPV: Grade D
- CJC-1295 / Ipamorelin vs SermorelinCJC-1295 / Ipamorelin: Grade CSermorelin: Grade B
- CJC-1295 / Ipamorelin vs TesamorelinCJC-1295 / Ipamorelin: Grade CTesamorelin: Grade A
- Sermorelin vs TesamorelinSermorelin: Grade BTesamorelin: Grade A
- MOTS-c vs EpitalonMOTS-c: Grade DEpitalon: Grade D
- Semax vs EpitalonSemax: Grade CEpitalon: Grade D
- Retatrutide vs MOTS-cRetatrutide: Grade BMOTS-c: Grade D
The monthly peptide evidence brief.
What the research and the FDA actually say, in one short email a month. Unsubscribe anytime.
No spam. We never sell your email. Editorial policy.